Advanced in Chronic Kidney Disease

Pascal Rischmann

Toulouse, FR 
Advanced in Chronic Kidney Disease
Toulouse, FR 
OverviewLocationsClinical Research

Overview

Pascal Rischmann practices in Toulouse, France. Mr. Rischmann is rated as an Advanced expert by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Neurogenic Bladder, Prostate Cancer, Chronic Kidney Disease, Prostatectomy, and Nephrectomy.

His clinical research consists of co-authoring 131 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Chronic Kidney Disease.

Gender
Male

Locations

Toulouse, France
Other Locations
CH Nord Ouest Val d'Oise
Pontoise, France
Ramonville-saint-agne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 2, Multicenter, Prospective Cohort Study, Estimating the Efficacy of Focused HIFU Therapy in Patients With Localized Intermediate Risk Prostate Cancer
Phase 2, Multicenter, Prospective Cohort Study, Estimating the Efficacy of Focused HIFU Therapy in Patients With Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2025
Intervention Type: Other, Device, Procedure, Biological
Study Drug: PSA
Study Phase: Phase 2
Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer
Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 22, 2025
Intervention Type: Device, Other, Procedure, Biological
Study Drug: PSA dosage
Study Phase: Phase 3
View 1 Less Clinical Trial

131 Total Publications

Reply to Mario Terlizzi, Youssef Ghannam, and Pierre Blanchard's Letter to the Editor re: Guillaume Ploussard, Patrick Coloby, Thierry Chevallier, et al. Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Radical Prostatectomy: The Prospective, Noninferiority, Nonrandomized HIFI Trial. Eur Urol. 2025;87:526-533.
Reply to Mario Terlizzi, Youssef Ghannam, and Pierre Blanchard's Letter to the Editor re: Guillaume Ploussard, Patrick Coloby, Thierry Chevallier, et al. Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Radical Prostatectomy: The Prospective, Noninferiority, Nonrandomized HIFI Trial. Eur Urol. 2025;87:526-533.
Journal: European urology
Published: February 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rischmann's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile